Literature DB >> 14607982

An in vivo model for monitoring trans-differentiation of bone marrow cells into functional hepatocytes.

Shuji Terai1, Isao Sakaida, Naoki Yamamoto, Kaoru Omori, Tomomi Watanabe, Shinya Ohata, Toshiaki Katada, Koji Miyamoto, Koh Shinoda, Hiroshi Nishina, Kiwamu Okita.   

Abstract

The plasticity of bone marrow cells (BMCs) remains controversial. The present study found that persistent injury induces efficient trans-differentiation of BMCs into functional hepatocytes. Mice with liver cirrhosis induced by carbon tetrachloride were injected with 1 x 10(5) non-treated green fluorescent protein (GFP)-positive BMCs via the tail vein. In these mice, transplanted GFP-positive BMCs efficiently migrated into the peri-portal area of liver lobules after one day, repopulating 25% of the recipient liver by 4 weeks. In contrast, no GFP-positive BMCs were detected following transplantation into control mice with undamaged livers. BMCs trans-differentiated into functional mature hepatocytes via immature hepatoblasts. Serum albumin levels were significantly elevated to compensate for chronic liver failure in BMC transplantation. These results reveal that recipient conditions and microenvironments represent key factors for successful cell therapy using BMCs.

Entities:  

Mesh:

Substances:

Year:  2003        PMID: 14607982     DOI: 10.1093/jb/mvg173

Source DB:  PubMed          Journal:  J Biochem        ISSN: 0021-924X            Impact factor:   3.387


  44 in total

1.  Differentiation and transplantation of human induced pluripotent stem cell-derived hepatocyte-like cells.

Authors:  Samira Asgari; Mohsen Moslem; Kamran Bagheri-Lankarani; Behshad Pournasr; Maryam Miryounesi; Hossein Baharvand
Journal:  Stem Cell Rev Rep       Date:  2013-08       Impact factor: 5.739

Review 2.  Hepatic stem cells: from inside and outside the liver?

Authors:  M R Alison; P Vig; F Russo; B W Bigger; E Amofah; M Themis; S Forbes
Journal:  Cell Prolif       Date:  2004-02       Impact factor: 6.831

Review 3.  Timeline for development of autologous bone marrow infusion (ABMi) therapy and perspective for future stem cell therapy.

Authors:  Shuji Terai; Haruko Tanimoto; Masaki Maeda; Junichi Zaitsu; Takuro Hisanaga; Takuya Iwamoto; Koichi Fujisawa; Yuko Mizunaga; Toshihiko Matsumoto; Yohei Urata; Yoshio Marumoto; Isao Hidaka; Tsuyoshi Ishikawa; Yuichiro Yokoyama; Koji Aoyama; Masako Tsuchiya; Taro Takami; Kaoru Omori; Naoki Yamamoto; Makoto Segawa; Koichi Uchida; Takahiro Yamasaki; Kiwamu Okita; Isao Sakaida
Journal:  J Gastroenterol       Date:  2012-04-05       Impact factor: 7.527

4.  Splenectomy enhances the anti-fibrotic effect of bone marrow cell infusion and improves liver function in cirrhotic mice and patients.

Authors:  Takuya Iwamoto; Shuji Terai; Yuko Mizunaga; Naoki Yamamoto; Kaoru Omori; Koichi Uchida; Takahiro Yamasaki; Yasuhiko Fujii; Hiroshi Nishina; Isao Sakaida
Journal:  J Gastroenterol       Date:  2011-11-09       Impact factor: 7.527

5.  Clinical application of bone marrow cell transplantation for liver diseases.

Authors:  Isao Sakaida
Journal:  J Gastroenterol       Date:  2006-01       Impact factor: 7.527

Review 6.  Adult stem cell plasticity: introduction to the first issue of stem cell reviews.

Authors:  Stewart Sell
Journal:  Stem Cell Rev       Date:  2005       Impact factor: 5.739

Review 7.  Emerging insights into Transforming growth factor beta Smad signal in hepatic fibrogenesis.

Authors:  Y Inagaki; I Okazaki
Journal:  Gut       Date:  2007-02       Impact factor: 23.059

Review 8.  Development of cell therapy using autologous bone marrow cells for liver cirrhosis.

Authors:  Isao Sakaida; Shuji Terai; Hiroshi Nishina; Kiwamu Okita
Journal:  Med Mol Morphol       Date:  2005-12       Impact factor: 2.309

Review 9.  Stem cells for liver tissue repair: current knowledge and perspectives.

Authors:  Philippe A Lysy; David Campard; Françoise Smets; Mustapha Najimi; Etienne M Sokal
Journal:  World J Gastroenterol       Date:  2008-02-14       Impact factor: 5.742

Review 10.  Supportive therapies for prevention of hepatocellular carcinoma recurrence and preservation of liver function.

Authors:  Taro Takami; Takahiro Yamasaki; Issei Saeki; Toshihiko Matsumoto; Yutaka Suehiro; Isao Sakaida
Journal:  World J Gastroenterol       Date:  2016-08-28       Impact factor: 5.742

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.